Benvenuto/a su DAIDEGAS FORUM, il primo forum di Moto del Mondo, creato da Davide Polo nel 2001. Se questa è la tua prima visita consulta le Domande frequenti e termini del sito b> facendo clic sul link sopra. E' necessario registrarsi b>
prima di poter postare: clicca sul link 'REGISTRARSI' qui sopra per procedere. Per iniziare a leggere i messaggi,
seleziona il forum che vuoi visitare dalla selezione qui sotto, la lettura è aperta al 100%.
Ma è sempre meglio partecipare no?
Announcement
Collapse
No announcement yet.
Announcement
Collapse
No announcement yet.
Coronavirus...opinioni non allineate capitolo 2 il ritorno...
APPROFITTANE!!!
Mancano solo parole chiave come "GRATIS" e "NOVITÀ"..un "SOLO PER OGGI"..e una donnina (e un omino per le donne) che ti ferma dicendo "PROPRIO TE CEECAVO.."
e ovviamente non avete capito il senso dell'articolo, ma d'altronde non è che ci possa aspettare niente di diverso dopo tutte le baggianate postate negli ultimi 2 anni
incollo le conclusioni:
In conclusion, in a cohort of 5.6 million people vaccinated against SARS-Cov-2, thrombosis, thrombocytopenia, and thrombosis with thrombocytopenia were very rare events. A similar safety signal was seen for VTE and thrombocytopenia (overall and specifically immune-related) was seen after first dose of both ChAdOx1 and BNT162b2, and of CVST after a first dose of ChAdOx1. Although the occurrence of VTE after vaccination was 1.1-fold above that expected in the general population, among those infected with SARS-CoV-2 it was more than 7-fold the background (expected) rate. Infection with SARS-CoV-2 prior to any vaccination against COVID-19 was also associated with increased risks of thrombocytopenia, arterial thromboembolism, and VTE with thrombocytopenia. These findings underline the relative safety of vaccines compared to the numerous ill-effects of being infected by SARS-CoV-2 for those people that remain unvaccinated.
In summary, this population-based study identifies and quantifies several rare neurological adverse events that are specific to the ChAdOx1nCoV-19 and BNT162b2 vaccines, as well as SARS-CoV-2 infection. We believe that these findings are likely to be of relevance to other countries using these vaccines and it would be useful to replicate these results in similarly large datasets internationally. Clinicians should be aware of these rare complications, and the findings from this study will be paramount to policy makers in risk–benefit evaluations and health-care resource allocation. Importantly, the risks of adverse neurological events following SARS-CoV-2 infection are much greater than those associated with vaccinations, highlighting the benefits of ongoing vaccination programs.
quindi: vaccini possono causare complicazioni? certo come tutti i farmaci. Rischio complicazioni covid rispetto a vaccino? molto maggiori
Ma la domanda è ...
68 Femminicidi in Italia (60M persone) ed è un problema grave per circa lo 0,0001%
Mentre gli eventi Avversi da Vaccino sono decisamente dippiù in % e pure numericamente ...
Quindi per te non sarebbe Gravissimo ???
Ma la domanda è ...
68 Femminicidi in Italia (60M persone) ed è un problema grave per circa lo 0,0001%
Mentre gli eventi Avversi da Vaccino sono decisamente dippiù in % e pure numericamente ...
Quindi per te non sarebbe Gravissimo ???
Per la scienza l'1% di effetti avversi è rarissimo.
e ovviamente non avete capito il senso dell'articolo, ma d'altronde non è che ci possa aspettare niente di diverso dopo tutte le baggianate postate negli ultimi 2 anni
incollo le conclusioni:
In conclusion, in a cohort of 5.6 million people vaccinated against SARS-Cov-2, thrombosis, thrombocytopenia, and thrombosis with thrombocytopenia were very rare events. A similar safety signal was seen for VTE and thrombocytopenia (overall and specifically immune-related) was seen after first dose of both ChAdOx1 and BNT162b2, and of CVST after a first dose of ChAdOx1. Although the occurrence of VTE after vaccination was 1.1-fold above that expected in the general population, among those infected with SARS-CoV-2 it was more than 7-fold the background (expected) rate. Infection with SARS-CoV-2 prior to any vaccination against COVID-19 was also associated with increased risks of thrombocytopenia, arterial thromboembolism, and VTE with thrombocytopenia. These findings underline the relative safety of vaccines compared to the numerous ill-effects of being infected by SARS-CoV-2 for those people that remain unvaccinated.
In summary, this population-based study identifies and quantifies several rare neurological adverse events that are specific to the ChAdOx1nCoV-19 and BNT162b2 vaccines, as well as SARS-CoV-2 infection. We believe that these findings are likely to be of relevance to other countries using these vaccines and it would be useful to replicate these results in similarly large datasets internationally. Clinicians should be aware of these rare complications, and the findings from this study will be paramount to policy makers in risk–benefit evaluations and health-care resource allocation. Importantly, the risks of adverse neurological events following SARS-CoV-2 infection are much greater than those associated with vaccinations, highlighting the benefits of ongoing vaccination programs.
quindi: vaccini possono causare complicazioni? certo come tutti i farmaci. Rischio complicazioni covid rispetto a vaccino? molto maggiori
Comment